We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

153 hedge funds and large institutions have $915M invested in Keryx Biopharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 66 increasing their positions, 40 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 40

16% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $13.9M

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 157 → 153 (-4)

14% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 28

23% less capital invested

Capital invested by funds: $1.19B → $915M (-$271M)

Holders
153
Holders Change
-4
Holders Change %
-2.55%
% of All Funds
4.12%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
24
Increased
66
Reduced
40
Closed
28
Calls
$16.2M
Puts
$13.9M
Net Calls
+$2.26M
Net Calls Change
+$3.99M

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$36.6M
2
State Street
State Street
Massachusetts
+$10.8M
3
BGIM
Brandywine Global Investment Management
Pennsylvania
+$9.59M
4
Invesco
Invesco
Georgia
+$6.02M
5
EAM
Eagle Asset Management
Florida
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$48.7M
2
CCM
Camber Capital Management
Massachusetts
-$26.8M
3
O
OppenheimerFunds
New York
-$12.3M
4
TCM
Tamarack Capital Management
California
-$12.1M
5
DM
Deerfield Management
New York
-$9.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$5.33M +$2.54M +237,000 +80%
CCM
27
Camber Capital Management
Massachusetts
$4.99M -$26.8M -2,500,000 -83%
GC
28
Guggenheim Capital
Illinois
$4.93M +$1.02M +94,673 +24%
RHJA
29
Rice Hall James & Associates
California
$4.47M -$464K -43,276 -9%
CWG
30
C WorldWide Group
Denmark
$4.19M -$5.26M -490,302 -54%
ARTA
31
A.R.T. Advisors
New York
$3.95M +$4.25M +395,913 New
1832 Asset Management
32
1832 Asset Management
Ontario, Canada
$3.66M -$395K -36,800 -9%
TCIM
33
TIAA CREF Investment Management
New York
$3.62M +$234K +21,810 +6%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$3.56M +$1.49M +138,585 +63%
BIM
35
BlackRock Investment Management
Delaware
$3.49M +$750K +69,957 +25%
PI
36
Putnam Investments
Massachusetts
$3.21M +$1.79M +166,946 +108%
Charles Schwab
37
Charles Schwab
California
$3.1M +$102K +9,530 +3%
Renaissance Technologies
38
Renaissance Technologies
New York
$2.95M +$3.17M +295,500 New
1CM
39
1492 Capital Management
Wisconsin
$2.64M -$156K -14,588 -5%
Ameriprise
40
Ameriprise
Minnesota
$2.56M +$374K +34,872 +16%
FPC
41
Falcon Point Capital
California
$2.51M +$1.95M +181,448 +260%
UBS Group
42
UBS Group
Switzerland
$2.5M -$926K -86,383 -26%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$2.39M – – –
GCM
44
Gruss Capital Management
New York
$2.38M – – –
TCM
45
Tributary Capital Management
Nebraska
$2.32M +$2.49M +232,600 New
ClearBridge Investments
46
ClearBridge Investments
New York
$2.17M -$15.8K -1,469 -0.7%
KCM
47
Knoll Capital Management
Florida
$2M – – –
Bank of America
48
Bank of America
North Carolina
$1.99M +$771K +71,883 +56%
Morgan Stanley
49
Morgan Stanley
New York
$1.92M +$54.7K +5,100 +3%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.89M +$42.7K +3,986 +2%
1
2
3 4 5

KERX Hedge Fund Activity: Q2 2015 in Review

153 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q2 2015, worth a combined $915M — down 23% from $1.19B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of KERX and 24 opened new positions — a net loss of 4 holders — while 40 trimmed existing stakes and 66 added.

The largest buyer was Baupost Group, adding an estimated $36.6M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $48.7M sold.

  • 153 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q2 2015, down from 157 in Q1 2015.
  • Funds reported $915M of Keryx Biopharmaceuticals Inc stock for Q2 2015, down 23% quarter-over-quarter.
  • 24 funds opened new Keryx Biopharmaceuticals Inc positions in Q2 2015 and 28 closed out, a net change of -4 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q2 2015 was Baupost Group, an estimated $36.6M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q2 2015 was Sectoral Asset Management, an estimated $48.7M sold.

Based on aggregated 13F filings for Q2 2015.